Current Oncology Reports

Papers
(The H4-Index of Current Oncology Reports is 29. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
Oligometastatic Esophagogastric Cancer: Does It Exist and How Do We Treat It?141
New Developments in VHL-Associated Neuroendocrine Neoplasms132
Cardiotoxic Effects Following CAR-T Cell Therapy: A Literature Review123
ChatGPT in Oncology Diagnosis and Treatment: Applications, Legal and Ethical Challenges83
Beneath the Surface: The Emerging Role of Ultra-Processed Foods in Obesity-Related Cancer81
Treatment Following Progression in Metastatic Melanoma: the State of the Art from Scientific Literature to Clinical Need74
Dealing with Family Conflicts in Decision-making in End-of-Life Care of Advanced Cancer Patients73
Toxicities from BRAF and MEK Inhibitors: Strategies to Maximize Therapeutic Success69
Richter’s Transformation69
Limb Amputations in Cancer: Modern Perspectives, Outcomes, and Alternatives65
Asparaginase: How to Better Manage Toxicities in Adults61
New Directions in Treatment of Metastatic or Advanced Pheochromocytomas and Sympathetic Paragangliomas: an American, Contemporary, Pragmatic Approach51
PEGylated IL-10: Clinical Development in Cancer Immunotherapy, Where to Go?48
Clonal Hematopoiesis of Indeterminate Potential: Current Understanding and Future Directions47
Oncolytic Viruses and Cancer Immunotherapy41
Advanced Pancreatic Neuroendocrine Neoplasms: Which Systemic Treatment Should I Start With?39
Surgery in the Era of Immunotherapy for Advanced Head and Neck Non-melanoma Skin Cancer39
What Causes Desmoplastic Reaction in Small Intestinal Neuroendocrine Neoplasms?37
Addressing Residual Disease in HER2-Positive and Triple-Negative Breast Cancer: What Is Next?35
BCR/ABL-Positive Chronic Myeloid Leukemia in Children: Current Treatment Approach33
Cardiotoxicity of Immune Checkpoint Inhibitors33
Germline Mutations and Ancestry in Prostate Cancer32
First-Line Treatment of Metastatic Non-Small Cell Lung Cancer in the Elderly32
New Insights on Tramadol and Immunomodulation31
Shifting Epidemiology of Hepatocellular Carcinoma in Far Eastern and Southeast Asian Patients: Explanations and Implications31
Graft-Versus-Host Disease: an Update on Functional Implications and Rehabilitation Interventions30
NRG1 Fusions: The New Kid on the Block30
Managing the Risk of Infection in Chronic Lymphocytic Leukemia in the Era of New Therapies30
Management of Pathologic Node-Positive Prostate Cancer following Radical Prostatectomy29
0.20908689498901